Clinical Trials Logo

Adrenocortical Hyperfunction clinical trials

View clinical trials related to Adrenocortical Hyperfunction.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03379363 Terminated - Cushing Syndrome Clinical Trials

Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome

Start date: September 18, 2017
Phase:
Study type: Observational

This retrospective, multi-center, chart review study will collect patient data from medical charts of pediatric patients who have been treated with Korlym for Cushing's syndrome.

NCT ID: NCT02001051 Terminated - Cushing Syndrome Clinical Trials

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

Start date: November 27, 2013
Phase: Phase 2
Study type: Interventional

Background: - Adrenal tumors are a common kind of tumor. Some of these secrete extra cortisol into the body, which can lead to diabetes, obesity, and other diseases. Some people with extra cortisol will show symptoms like bruising and muscle weakness. Others will show no signs. This is called subclinical hypercortisolism. Some of these adrenal tumors become malignant. Researchers want to know the best way to treat people with subclinical hypercortisolism. They want to know if removing the tumor by surgery reduces the long-term effects of the disease. Objectives: - To see if removing an adrenal tumor by surgery improves blood pressure, diabetes, obesity, osteoporosis, or cholesterol, and cancer detection. Eligibility: - Adults 18 and older with an adrenal tumor and high cortisol levels. Design: - Participants will be screened with medical history, blood tests, and a computed tomography (CT) scan. - Participants will have a baseline visit. They will have blood and urine tests and 7 scans. For most scans, a substance is injected through a tube in the arm. Participants will lie still on a table in a machine that takes images. - Participants will have surgery to remove their tumor. Some will have surgery right away. Some will have surgery 6 months later, after 2 follow-up appointments. - Participants will have 4 follow-up visits in the first year after surgery. They will have 2 visits the second year, then yearly visits for 3 years. At each follow-up visit, they will have scans and blood tests.

NCT ID: NCT01246739 Terminated - Clinical trials for Adrenal Tumour With Mild Hypercortisolism

Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome

AUSC
Start date: June 2011
Phase: N/A
Study type: Interventional

Incidental findings of adrenal tumours,"incidentalomas", occur in 1-5 % in the general population and 10-25 % of these patients will exhibit biochemical mild hypercortisolism. Although the patients do not have clinical signs of classical Cushing's syndrome, they have an increased risk for hypertension, dyslipidemia, diabetes mellitus, osteoporosis and obesity. The hypothesis of the study is, that surgery of the adrenal adenoma responsible for the increased secretion of cortisol, will in part cure or ameliorate the metabolic syndrome.

NCT ID: NCT00796783 Terminated - Cushing's Syndrome Clinical Trials

A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia

Start date: February 2009
Phase: N/A
Study type: Observational

This is an observational study to confirm the presence of recurrent or persistent endogenous Cushing's syndrome in patients who have had primary surgical and/or radiation therapy for Cushing's disease and continue to manifest symptoms and signs of hypercortisolemia.